Department of Medicine Archive — Page 49 of 122
-
August 2, 2022
Targeted cancer drug during pregnancy
The targeted cancer therapy alectinib was safe as a treatment for lung cancer during two pregnancies in a patient with non-small cell lung cancer, according to a case report from Vanderbilt physicians. -
August 1, 2022
VWCH relaunches interventional cardiology program
Vanderbilt Wilson County Hospital has launched a percutaneous coronary intervention program to treat patients diagnosed with heart attacks and coronary artery disease. -
August 1, 2022
H. pylori and lung cancer
Specific biomarkers for H. pylori — a bacterium that infects the stomach — were associated with increased risk of lung cancer, Vanderbilt researchers have discovered. -
July 28, 2022
Video vital for telehealth visits
Vanderbilt study of 18,130 telehealth visits at the beginning of the COVID-19 pandemic defines risk factors associated with telehealth access and suggests how health systems can improve access. -
July 28, 2022
Department of Medicine announces August Grand Rounds
-
July 28, 2022
Study reveals need for matching targeted therapies with EGFR subtypes
A Vanderbilt study suggests that clinicians should take a deeper dive into distinguishing EGFR mutations when prescribing targeted therapies for non-small-cell lung cancers. -
July 21, 2022
Study explores role RSV plays in later asthma development
A Vanderbilt clinical project will follow 1,950 Middle Tennessee children to determine how genes and the environment interact with RSV infection during the first year of life and contribute to asthma development